GenMark Diagnostics, Inc. (Nasdaq: GNMK), has priced an underwritten public offering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE